Ms. Will joins PharPoint as the company continues to grow and engage an increasing number of biotech and pharmaceutical clients seeking personalized attention, therapeutically aligned expertise, industry-best timelines, and decentralized study options.
As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health.
RESEARCH TRIANGLE PARK, N.C. (June 1, 2016) — PharPoint Research, a U.S.-based contract research organization (CRO), today announced the expansion of their clinical trial management and consulting service capabilities into Europe. The extension provides PharPoint Research’s global drug development clients greater access to increasingly meaningful markets and increases their reach across the European continent. With rising…
PharPoint Research, Inc., a drug development service company providing biostatistics and data management services to the pharmaceutical and biotechnology industries, announces that it has incorporated Medrio’s EDC technology platform into its growing suite of data management applications. “The addition of Medrio’s EDC solution to our existing offerings further supports PharPoint’s ability to consistently exceed our…
Medidata Solutions (NASDAQ: MDSO), a leading global provider of SaaS-based clinical development solutions, announced that PharPoint Research, Inc., a North Carolina-based drug development service company, has joined Medidata’s ASPire to Win® channel partner program, bringing the program’s partner count to 30 organizations. With this partnership, PharPoint will be able to offer the Medidata Rave® electronic data capture (EDC) and clinical data…
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.